Guangzhou Jet Bio-Filtration Co., Ltd. (SHA:688026)

Market Cap	2.88B +6.8%
Revenue (ttm)	573.29M -2.9%
Net Income	22.71M -75.3%
EPS	0.16 -75.1%
Shares Out	135.81M
PE Ratio	129.73
Forward PE	36.53
Dividend	0.07 (0.36%)
Ex-Dividend Date	Jul 31, 2026

Volume	4,016,379
Open	21.63
Previous Close	21.21
Day's Range	20.88 - 21.63
52-Week Range	11.26 - 23.11
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About SHA:688026

Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration, molecular biology, cellsafe, medical consumables, biological reagents, medical devices, laboratory instruments, and customization services. The company was founded in 2001 and is headquartered in Guangzhou, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 1,490
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688026

Financial Performance

In 2025, SHA:688026's revenue was 563.98 million, an increase of 0.95% compared to the previous year's 558.66 million. Earnings were 48.24 million, a decrease of -36.23%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 14, 2026

Data Sources Report a data error